X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-02-03 | IMNPQ | Fiorino Anthony S. | Dir | S - Sale | $0.00 | -75,000 | 0 | -100% | -$263 | ||||||
2018-05-22 | IMNP | Fiorino Anthony S. | Chief Medical Officer, COO | P - Purchase | $0.24 | +25,000 | 75,000 | +50% | +$5,978 | ||||||
2018-05-17 | IMNP | Fiorino Anthony S. | Chief Medical Officer, COO | P - Purchase | $0.26 | +50,000 | 50,000 | New | +$12,900 | ||||||
2017-01-04 | IMNP | Kazado Daniel | Dir | P - Purchase | $0.19 | +76,503 | 1,145,171 | +7% | +$14,222 | +11 | +6 | +11 | |||
2016-12-16 | IMNP | Kazado Daniel | Dir | P - Purchase | $0.19 | +161,377 | 1,068,667 | +18% | +$30,000 | -1 | -6 | +16 | |||
| A | 2016-08-04 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.41 | +868,902 | 5,679,807 | +18% | +$356,250 | -5 | -13 | -24 | -57 | |
| D | 2016-08-04 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.38 | +937,500 | 5,748,405 | +19% | +$356,250 | +15 | +19 | +3 | -36 | |
2016-08-04 | IMNP | Luchi Monica E. | EVP, CMO | P - Purchase | $0.45 | +777,778 | 777,778 | New | +$350,000 | +15 | +19 | +3 | -36 | ||
2016-08-04 | IMNP | Kazado Daniel | Dir | P - Purchase | $0.45 | +666,667 | 907,290 | +277% | +$300,000 | +15 | +19 | +3 | -36 | ||
2016-01-26 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.59 | +42,000 | 4,810,905 | +1% | +$24,826 | -10 | -2 | -20 | -32 | ||
2016-01-19 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.57 | +44,200 | 4,768,905 | +1% | +$25,000 | -5 | +4 | +11 | -13 | ||
2016-01-12 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.62 | +39,400 | 4,724,705 | +1% | +$24,597 | -11 | -12 | -22 | -15 | ||
2016-01-05 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.81 | +62,000 | 4,685,305 | +1% | +$49,972 | -2 | -22 | -46 | -53 | ||
2015-12-07 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $0.76 | +65,400 | 4,623,305 | +1% | +$49,926 | -7 | -5 | +4 | -29 | ||
2015-12-07 | IMNP | Kazado Daniel | Dir | P - Purchase | $0.78 | +150,000 | 240,623 | +166% | +$117,105 | -7 | -5 | +4 | -29 | ||
2015-10-26 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $1.36 | +18,400 | 4,557,905 | 0% | +$25,000 | -1 | -4 | -37 | -70 | ||
2015-10-19 | IMNP | Teper Daniel Gedeon | CEO | P - Purchase | $1.34 | +18,600 | 4,539,505 | 0% | +$24,998 | 0 | -3 | -23 | -68 | ||
2015-10-12 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $1.30 | +19,000 | 4,520,905 | 0% | +$24,708 | +12 | +5 | +7 | -66 | ||
2015-10-05 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $1.23 | +40,700 | 4,501,905 | +1% | +$49,927 | +3 | +11 | +12 | -57 | ||
2015-09-14 | IMNP | Azria Rene Pierre | Dir | P - Purchase | $1.48 | +50,000 | 50,000 | New | +$73,850 | +3 | 0 | -10 | -72 | ||
2015-09-14 | IMNP | Kazado Daniel | Dir | P - Purchase | $1.47 | +50,000 | 90,623 | +123% | +$73,480 | +3 | 0 | -10 | -72 | ||
2015-09-01 | IMNP | Teper Daniel Gedeon | CEO, 10% | P - Purchase | $1.29 | +7,569 | 4,461,205 | 0% | +$9,799 | -3 | +8 | -5 | -58 | ||
| D | 2014-11-26 | IMNP | Kazado Daniel | Dir | P - Purchase | $2.50 | +8,000 | 8,392 | >999% | +$20,000 | +2 | -1 | -20 | -14 | |
| D | 2014-11-26 | IMNP | Stancic Ana | Dir | P - Purchase | $2.50 | +8,000 | 8,000 | New | +$20,000 | +2 | -1 | -20 | -14 | |
| D | 2014-11-26 | IMNP | Berdugo Gad | Dir | P - Purchase | $2.50 | +8,000 | 8,000 | New | +$20,000 | +2 | -1 | -20 | -14 | |
| D | 2014-11-26 | IMNP | Durrant Cameron | Dir | P - Purchase | $2.50 | +4,000 | 4,000 | New | +$10,000 | +2 | -1 | -20 | -14 | |
| D | 2014-11-26 | IMNP | Sidransky David | Dir | P - Purchase | $2.50 | +10,400 | 18,290 | +132% | +$26,000 | +2 | -1 | -20 | -14 | |
| D | 2007-12-12 | EPCT | Wiedemann Oliver | MD-See Remarks | P - Purchase | $1.40 | +5,000 | 5,000 | New | +$7,000 | |||||
2007-12-13 | EPCT | Savage Robert G | Dir | P - Purchase | $1.38 | +30,000 | 70,100 | +75% | +$41,338 | ||||||
2007-12-12 | EPCT | Bhagwat Dileep | SVP-Pharmaceutical Development | P - Purchase | $1.43 | +10,000 | 12,500 | +400% | +$14,275 | ||||||
| M | 2007-09-13 | EPCT | Allard Stephane | Chief Medical Officer | P - Purchase | $1.43 | +45,600 | 81,200 | +128% | +$65,104 | |||||
2007-12-13 | EPCT | Talley John V | Pres, CEO, Dir | P - Purchase | $1.40 | +15,000 | 117,146 | +15% | +$21,000 | ||||||
2007-12-13 | EPCT | Cook Robert W | CFO-SVP, Finance, Admin. | P - Purchase | $1.35 | +5,000 | 15,000 | +50% | +$6,750 | ||||||
2007-09-04 | EPCT | Bedard John F | Dir | P - Purchase | $1.68 | +2,000 | 2,000 | New | +$3,360 | ||||||
| M | 2007-08-29 | EPCT | Cook Robert W | CFO-SVP, Finance, Admin. | P - Purchase | $1.67 | +10,000 | 10,000 | New | +$16,654 | |||||
2007-08-28 | EPCT | Talley John V | Pres, CEO, Dir | P - Purchase | $1.65 | +10,000 | 102,146 | +11% | +$16,489 | ||||||
2007-08-24 | EPCT | Bhagwat Dileep | SVP-Pharmaceutical Development | P - Purchase | $1.60 | +1,500 | 2,500 | +150% | +$2,400 | ||||||
2007-08-23 | EPCT | Bhagwat Dileep | SVP-Pharmaceutical Development | P - Purchase | $1.61 | +1,000 | 1,000 | New | +$1,612 | ||||||
2007-08-21 | EPCT | Savage Robert G | Dir | P - Purchase | $1.59 | +28,600 | 73,700 | +63% | +$45,596 | ||||||
2007-08-20 | EPCT | Savage Robert G | Dir | P - Purchase | $1.58 | +7,500 | 17,500 | +75% | +$11,824 | ||||||
2007-08-17 | EPCT | Savage Robert G | Dir | P - Purchase | $1.58 | +4,000 | 4,000 | New | +$6,300 | ||||||
2006-06-13 | EPCT | Jackson Guy C | Dir | P - Purchase | $2.70 | +5,000 | 300 | -106% | +$13,497 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |